MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00535-024-02083-1

Медицинская библиотека · Journal of gastroenterology · 2024

Pancreatic injury in patients treated with immune checkpoint inhibitors: a retrospective multicenterstudy.

Nagao Kae, Sakai Arata, Tsumura Hidetaka, Iemoto Takao, Hirata Yuichi, Hori Hitomi, Ogisu Kyohei, Kakuyama Saori, Ikegawa Takuya, Hirata Tamaki, Ezaki Takeshi, Furumatsu Keisuke, Yamanaka Kodai, Kato Takao, Fujigaki Seiji, Tanaka Hidenori, Yagi Yosuke, Tanaka Takeshi, Kobayashi Takashi, Masuda Atsuhiro, Shiomi Hideyuki, Kodama Yuzo

СтатьяМногоцентровое исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Immune checkpoint inhibitor-related pancreatic injury (ICI-PI) is a rare occurrence, which has not been reported in detail. We conducted a retrospective multicenter study to determine the clinical characteristics, risk factors, and treatment of ICI-PI.

METHODS

We reviewed the medical records of patients who received ICIs for malignant tumors between April 2014 and April 2019 at 16 participating hospitals. Patients with elevated pancreatic enzymes or pancreatitis were identified and classified using the Common terminology Criteria for Adverse Events (CTCAE) ver.5.0). The number of patients with pancreatic enzyme elevation was determined and those with pancreatic enzyme elevation of ≥ grade 3 according to CTCAE ver.5.0, or pancreatitis underwent detailed analysis for ICI-PI.

RESULTS

The study enrolled 1069 patients. Nineteen patients (1.8%) had ICI-PI, 5 (0.5%) of whom also had pancreatitis. Four patients had mild pancreatitis, whereas 1 patient had severe pancreatitis, culminating in death. Steroid therapy was administered to 7 of 19 patients, which led to ICI-PI improvement in 5 patients. On the other hand, ICI-PI improved in 9 of 12 patients who were not administered steroid therapy. Six of the 14 patients with ICI-PI improvement were rechallenged with ICI, and ICI-PI relapse occurred in only 1 patient (16.7%), which improved with ICI discontinuation and steroid therapy.

CONCLUSIONS

ICI-PI is a rare occurrence, with a low incidence of pancreatitis, which followed a very serious course in one patient. Although the benefit of steroid therapy for ICI-PI is unclear, ICI rechallenge is acceptable after improvement of ICI-PI without pancreatitis.

Для цитирования: Nagao Kae, Sakai Arata, Tsumura Hidetaka, Iemoto Takao, Hirata Yuichi, Hori Hitomi, Ogisu Kyohei, Kakuyama Saori, Ikegawa Takuya, Hirata Tamaki, Ezaki Takeshi, Furumatsu Keisuke, Yamanaka Kodai, Kato Takao, Fujigaki Seiji, Tanaka Hidenori, Yagi Yosuke, Tanaka Takeshi, Kobayashi Takashi, Masuda Atsuhiro, Shiomi Hideyuki, Kodama Yuzo. Pancreatic injury in patients treated with immune checkpoint inhibitors: a retrospective multicenterstudy.. Journal of gastroenterology. 2024. DOI: 10.1007/s00535-024-02083-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.